53 related articles for article (PubMed ID: 8589277)
1. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype.
Rivoltini L; Arienti F; Orazi A; Cefalo G; Gasparini M; Gambacorti-Passerini C; Fossati-Bellani F; Parmiani G
Cancer Immunol Immunother; 1992; 34(4):241-51. PubMed ID: 1311218
[TBL] [Abstract][Full Text] [Related]
3. Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas.
Voutsas IF; Baxevanis CN; Gritzapis AD; Missitzis I; Stathopoulos GP; Archodakis G; Banis C; Voelter W; Papamichail M
Cancer Immunol Immunother; 2000 Oct; 49(8):449-58. PubMed ID: 11043852
[TBL] [Abstract][Full Text] [Related]
4. Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes.
Ioannides CG; Fisk B; Tomasovic B; Pandita R; Aggarwal BB; Freedman RS
Cancer Immunol Immunother; 1992; 35(2):83-91. PubMed ID: 1534515
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of cytotoxic T cells generated by short-term culture of human peripheral blood lymphocytes with interleukin-2 and anti-CD3 mAb.
Jacobs N; Greimers R; Mazzoni A; Trebak M; Schaaf-Lafontaine N; Boniver J; Moutschen MP
Cancer Immunol Immunother; 1996 Jul; 42(6):369-75. PubMed ID: 8830741
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells.
Hoon DS; Hayashi Y; Morisaki T; Foshag LJ; Morton DL
Cancer Immunol Immunother; 1993 Nov; 37(6):378-84. PubMed ID: 8242663
[TBL] [Abstract][Full Text] [Related]
7. Lysing of fresh human tumor by a cytotoxic factor derived from autologous large granular lymphocytes independently of other known cytokines.
Uchida A; Fujimoto T; Mizutani Y
Cancer Immunol Immunother; 1990; 31(1):60-4. PubMed ID: 2106392
[TBL] [Abstract][Full Text] [Related]
8. Characterization and augmentation of CD4+ cytotoxic T cell lines against melanoma.
Morisaki T; Morton DL; Uchiyama A; Yuzuki D; Barth A; Hoon DS
Cancer Immunol Immunother; 1994 Sep; 39(3):172-8. PubMed ID: 7923247
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic activity and phenotypic characteristics of lymphocyte subsets after therapy of cancer patients with interleukin-2.
Weidmann E; Bergmann L; Hechler P; Mitrou PS
Cancer Immunol Immunother; 1991; 33(6):398-402. PubMed ID: 1878892
[TBL] [Abstract][Full Text] [Related]
10. Killer cells induced by stimulation with allogeneic tumor cells and subsequent culture with recombinant interleukin-2.
Fukiage T; Murakami H; Eura M; Ikawa T; Ishikawa T
Cancer Immunol Immunother; 1991; 33(3):139-45. PubMed ID: 1646074
[TBL] [Abstract][Full Text] [Related]
11. Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells.
Vánky F; Stuber G; Rotstein S; Klein E
Cancer Immunol Immunother; 1989; 28(1):17-21. PubMed ID: 2462466
[TBL] [Abstract][Full Text] [Related]
12. Emergence of non-major-histocompatibility-complex-restricted lytic CD8+ cells in the blood of nasopharyngeal carcinoma patients.
Lakhdar M; Thameur H; Maalej M; Ben Ayed F; Ladgham A
Cancer Immunol Immunother; 1993 Jul; 37(2):131-9. PubMed ID: 8391392
[TBL] [Abstract][Full Text] [Related]
13. The role of major histocompatibility complex expression on head and neck cancer cells in the induction of autologous cytotoxic T lymphocytes.
Chikamatsu K; Eura M; Matsuoka H; Murakami H; Fukiage T; Ishikawa T
Cancer Immunol Immunother; 1994 Jun; 38(6):358-64. PubMed ID: 8205556
[TBL] [Abstract][Full Text] [Related]
14. Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients.
Nouri AM; Dorey E; Davis CL; Rohatiner A; Lister TA; Oliver RT
Cancer Immunol Immunother; 1993 Jul; 37(1):47-53. PubMed ID: 8513452
[TBL] [Abstract][Full Text] [Related]
15. Long-term serum/plasma-free culture of human cytotoxic T lymphocytes induced from peripheral blood mononuclear cells.
Liu SQ; Shiba R; Kim BS; Saijo K; Ohno T
Cancer Immunol Immunother; 1994 Nov; 39(5):279-85. PubMed ID: 7987858
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta, (TGFbeta) secreted by immunogenic ex vivo human carcinoma cells, counteracts the activation and inhibits the function of autologous cytotoxic lymphocytes. Pretreatment with interferon gamma and tumor necrosis factor alpha reduces the production of active TGFbeta.
Nagy N; Vánky F
Cancer Immunol Immunother; 1998 Feb; 45(6):306-12. PubMed ID: 9490200
[TBL] [Abstract][Full Text] [Related]
17. Antitumor response of regional lymph node lymphocytes in human lung cancer.
Takenoyama M; Yasumoto K; Harada M; Sugimachi K; Nomoto K
Cancer Immunol Immunother; 1998 Dec; 47(4):213-20. PubMed ID: 9875674
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model.
Renard I; Mezzanzanica D; Canevari S; Ferrini S; Boniver J; Delvenne P; Jacobs N
Am J Pathol; 2002 Jan; 160(1):113-22. PubMed ID: 11786405
[TBL] [Abstract][Full Text] [Related]
19. Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes.
Vánky F; Stuber G; Willems J; Sjöwall K; Larsson B; Böök K; Ivert T; Péterffy A; Klein E
Cancer Immunol Immunother; 1988; 27(3):213-22. PubMed ID: 2972365
[TBL] [Abstract][Full Text] [Related]
20. The polysaccharide K (PSK) potentiates in vitro activation of the cytotoxic function in human blood lymphocytes by autologous tumour cells.
Vánky F; Wang P; Klein E
Cancer Immunol Immunother; 1992; 35(3):193-8. PubMed ID: 1638556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
